Green Shield Canada

Beta-3-adrenoceptor agonist offers alternative to decades-old treatments

New Brunswick pharmacists have been busy fielding calls from anxious patients after news of an urgent recall of Alysena-28 birth control pills broke last Monday, the CBC reported.

The recent discovery that nearly 1,200 cancer patients received diluted chemotherapy drugs has the Ontario government scrambling to get regulations in place to govern private companies that prepare such medications.

Review highlights complexity of pharmaceutical out-sourcing system.

Forest Laboratories will soon launch a new once-daily beta-blocker for the treatment of mild to moderate essential hypertension.

Maximizing the likelihood of treatment success